Les nouveaux anticoagulants oraux directs (NACO) chez le sujet âgé : point de vue de l’urgentiste

The NOACs are increasingly prescribed in France. Their effectiveness and their adverse effects appear to be in line with initial randomized studies. However, studies are missing in special populations, geriatric population for example, before their widespread prescription. Under medical supervision provided, these drugs can be started in the ER, in well-targeted patients.